Distal deletion 9p syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1642Q93.5
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal deletion 9p syndrome (also known as 9p minus syndrome, monosomy 9p, or partial deletion of the short arm of chromosome 9) is a rare chromosomal disorder caused by the loss of genetic material from the distal (far end) portion of the short arm of chromosome 9. The critical region most commonly deleted involves band 9p22-p24, and the size of the deletion can vary among affected individuals, contributing to a spectrum of clinical severity. The condition affects multiple body systems. Key clinical features include intellectual disability of variable degree, characteristic craniofacial dysmorphism (trigonocephaly or metopic ridging, flat nasal bridge, long philtrum, midface hypoplasia, upslanting palpebral fissures, and anteverted nares), and genital anomalies, particularly in males, which may include hypospadias, cryptorchidism, and in some cases ambiguous genitalia or 46,XY disorders of sex development. Cardiac malformations, inguinal hernias, and hypotonia may also be present. Some individuals exhibit behavioral difficulties and speech delay. There is no cure for distal deletion 9p syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific clinical manifestations. This may include early intervention programs, speech and occupational therapy, surgical correction of cardiac or genital anomalies, and ongoing developmental and educational support. Genetic counseling is recommended for affected families to assess recurrence risk, particularly when the deletion arises from a balanced parental chromosomal rearrangement.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal antihelix morphologyHP:0009738Hypoplastic labia majoraHP:0000059Aplasia/Hypoplasia of the earlobesHP:0009906Abnormal helix morphologyHP:0011039Enlarged thoraxHP:0100625
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2017Chromosome 9 P Minus Syndrome

Washington University School of Medicine

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Distal deletion 9p syndrome.

View clinical trials →

No actively recruiting trials found for Distal deletion 9p syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal deletion 9p syndrome community →

Specialists

1 foundView all specialists →
FM
F. S Cole, M.D.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal deletion 9p syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal deletion 9p syndromeForum →

No community posts yet. Be the first to share your experience with Distal deletion 9p syndrome.

Start the conversation →

Latest news about Distal deletion 9p syndrome

Disease timeline:

New recruiting trial: Chromosome 9 P Minus Syndrome

A new clinical trial is recruiting patients for Distal deletion 9p syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal deletion 9p syndrome

What is Distal deletion 9p syndrome?

Distal deletion 9p syndrome (also known as 9p minus syndrome, monosomy 9p, or partial deletion of the short arm of chromosome 9) is a rare chromosomal disorder caused by the loss of genetic material from the distal (far end) portion of the short arm of chromosome 9. The critical region most commonly deleted involves band 9p22-p24, and the size of the deletion can vary among affected individuals, contributing to a spectrum of clinical severity. The condition affects multiple body systems. Key clinical features include intellectual disability of variable degree, characteristic craniofacial dysm

At what age does Distal deletion 9p syndrome typically begin?

Typical onset of Distal deletion 9p syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Distal deletion 9p syndrome?

1 specialists and care centers treating Distal deletion 9p syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.